American Botanical Council
ABC Releases Monograph on Scientific Research of POM Wonderful(R) Pomegranate Juice
Published in Cancer Weekly, August 26th, 2008
The monograph includes summaries of 6 clinical trials, in which POM Wonderful Pomegranate Juice was evaluated for its effects on cardiovascular disease, prostate cancer, and erectile dysfunction. The authors of the monograph further provide information on the active constituents and safety of pomegranate juice, as well as distinguishing characteristics particular to POM Wonderful Pomegranate Juice.
"When ABC approached POM Wonderful about doing a monograph, we thought this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-08-26)
More Articles from Cancer Weekly
- Duke University Medical Center
Study finds more PSA screening awareness needed among high-risk groups - Journal of the National Cancer Institute
Prostatectomy improves outcome of some men with prostate cancer over watchful waiting - Wiley-Blackwell
1 in 5 young men has had recent prostate cancer test - American Botanical Council
ABC Releases Monograph on Scientific Research of POM Wonderful Pomegranate Juice - Bioengineering
Findings from University of Maryland advance knowledge in bioengineering - Cancer
EntreMed Teams with JSB-Partners to Expedite Partnering of its Aurora Kinase Program - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
